1643408

テマゼパム

United States Pharmacopeia (USP) Reference Standard

• 実験式（ヒル表記法）: C₁₆H₁₃ClN₂O₂
• CAS番号: 846-50-4
• 分子量: 300.74
• MDL番号: MFCD00057904
• UNSPSCコード: 41116107
• PubChem Substance ID: 329751226
• NACRES: NA.24

特性

• グレード: pharmaceutical primary standard
• APIファミリー: temazepam
• メーカー／製品名: USP
• 薬剤管理: USDEA Schedule IV; regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)
• アプリケーション: pharmaceutical (small molecule)
• フォーマット: neat
• 保管温度: 2-8°C
• SMILES記法: CN1C(=O)C(O)N=C(c2ccccc2)c3cc(Cl)ccc13
• InChI: 1S/C16H13ClN2O2/c1-19-13-8-7-11(17)9-12(13)14(18-15(20)16(19)21)10-5-3-2-4-6-10/h2-9,15,20H,1H3
• InChI Key: SEQDDYPDSLOBDC-UHFFFAOYSA-N
• 遺伝子情報: human ... GABRA1(2554) , GABRA2(2555) , GABRA3(2556) , GABRA4(2557) , GABRA5(2558) , GABRA6(2559) , GABRB1(2560) , GABRB2(2561) , GABRB3(2562) , GABRD(2563) , GABRE(2564) , GABRG1(2565) , GABRG2(2566) , GABRG3(2567) , GABRP(2568) , GABRQ(55879)

詳細

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

アナリシスノート

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS07
• シグナルワード: Warning
• 危険有害性情報: H302 - H336
• 注意書き: P301 + P312 + P330
• 危険有害性の分類: Acute Tox. 4 Oral - STOT SE 3
• ターゲットの組織: Central nervous system
• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable